ROP Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed Roku Q1 2026 Earnings Strong Profit Beat Signals Operating Discipline Immunome Inc IMNM Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech ABUS Q1 2026 Earnings EPS Miss Reflects Continued RD Investment as Pipeline Progresses LBRDA Q3 2025 Earnings EPS Surges Past Estimates Despite Broadband Headwinds